Drug intelligence / Profile preview

oxandrolone + propranolol

Development stage
Phase 3
Lead developer
Bio-Technology General
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Oxandrolone + propranolol is a combination therapy of two small molecule drugs—oxandrolone, an anabolic steroid and synthetic testosterone analog, and propranolol, a non-selective beta-adrenergic receptor antagonist (beta-blocker). This combination has been studied primarily in pediatric patients with severe burns. Oxandrolone promotes protein synthesis and lean body mass accretion to counteract muscle wasting, while propranolol reduces cardiac work and resting energy expenditure by blocking the effects of elevated catecholamines after burn injury. Together, these agents have demonstrated synergistic benefits in attenuating burn-induced growth arrest, accelerating muscle recovery, increasing growth rate, improving lean body mass accrual, enhancing muscle strength and power during rehabilitative exercise training programs in severely burned children[1][2][4][6][7]. The combination does not alter the pharmacokinetics or plasma concentrations of either drug when coadministered[5].

Other names
Oxprop
02

Targets

ADRB1 (β1)ADRB2 (β2)

Beyond the preview

Go deeper on oxandrolone + propranolol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxandrolone + propranolol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call